Banner K[au] - Search Results

Year	Number of Results
1995	5
1996	4
1999	2
2000	1
2001	1
2003	1
2004	2
2005	1
2006	2
2007	1
2008	4
2009	3
2010	1
2011	2
2013	1
2015	1
2016	2
2017	2
2018	1
2019	2
2020	2
2021	1
2022	1

1

TRP channels: emerging targets for respiratory disease.

Banner KH, Igney F, Poll C. Banner KH, et al. Pharmacol Ther. 2011 Jun;130(3):371-84. doi: 10.1016/j.pharmthera.2011.03.005. Epub 2011 Mar 21. Pharmacol Ther. 2011. PMID: 21420429 Review.

2

Challenges and opportunities for comparative studies of survival rates: An example with male pinnipeds.

Brusa JL, Rotella JJ, Banner KM, Hutchins PR. Brusa JL, et al. Among authors: banner km. Ecol Evol. 2021 May 8;11(12):7980-7999. doi: 10.1002/ece3.7627. eCollection 2021 Jun. Ecol Evol. 2021. PMID: 34188866 Free PMC article.

3

PDE4 inhibitors - a review of the current field.

Press NJ, Banner KH. Press NJ, et al. Among authors: banner kh. Prog Med Chem. 2009;47:37-74. doi: 10.1016/S0079-6468(08)00202-6. Prog Med Chem. 2009. PMID: 19328289 Review. No abstract available.

4

Highlights of a workshop to discuss targeting inflammation in cystic fibrosis.

Banner KH, De Jonge H, Elborn S, Growcott E, Gulbins E, Konstan M, Moss R, Poll C, Randell SH, Rossi AG, Thomas L, Waltz D. Banner KH, et al. J Cyst Fibros. 2009 Jan;8(1):1-8. doi: 10.1016/j.jcf.2008.10.002. Epub 2008 Nov 20. J Cyst Fibros. 2009. PMID: 19022708 Free PMC article. Review.

5

Amphiregulin contributes to airway remodeling in chronic allograft dysfunction after lung transplantation.

Todd JL, Kelly FL, Nagler A, Banner K, Pavlisko EN, Belperio JA, Brass D, Weigt SS, Palmer SM. Todd JL, et al. Among authors: banner k. Am J Transplant. 2020 Mar;20(3):825-833. doi: 10.1111/ajt.15667. Epub 2019 Dec 1. Am J Transplant. 2020. PMID: 31665560 Free PMC article.

6

Anti-inflammatory effects of theophylline and selective phosphodiesterase inhibitors.

Banner KH, Page CP. Banner KH, et al. Clin Exp Allergy. 1996 Mar;26 Suppl 2:2-9. doi: 10.1111/j.1365-2222.1996.tb01136.x. Clin Exp Allergy. 1996. PMID: 8963872 Free article. Review. No abstract available.

7

Considerations for assessing model averaging of regression coefficients.

Banner KM, Higgs MD. Banner KM, et al. Ecol Appl. 2017 Jan;27(1):78-93. doi: 10.1002/eap.1419. Epub 2016 Nov 22. Ecol Appl. 2017. PMID: 27874997

8

Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease.

Banner KH, Press NJ. Banner KH, et al. Br J Pharmacol. 2009 Jul;157(6):892-906. doi: 10.1111/j.1476-5381.2009.00170.x. Epub 2009 Jun 5. Br J Pharmacol. 2009. PMID: 19508401 Free PMC article. Review.

9

PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease.

Banner KH, Trevethick MA. Banner KH, et al. Trends Pharmacol Sci. 2004 Aug;25(8):430-6. doi: 10.1016/j.tips.2004.06.008. Trends Pharmacol Sci. 2004. PMID: 15276712 Review.

10

Pharmacology of a new cyclic nucleotide phosphodiesterase type 4 inhibitor, V11294.

Gale DD, Hofer P, Spina D, Seeds EA, Banner KH, Harrison S, Douglas G, Matsumoto T, Page CP, Wong RH, Jordan S, Smith F, Banik N, Halushka PV, Cavalla D, Rotshteyn Y, Kyle DJ, Burch RM, Chasin M. Gale DD, et al. Among authors: banner kh. Pulm Pharmacol Ther. 2003;16(2):97-104. doi: 10.1016/S1094-5539(02)00175-X. Pulm Pharmacol Ther. 2003. PMID: 12670778 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results